VAERS reports by lot

Pfizer COVID-19 lot FR2587: VAERS reports

412 VAERS reports list lot FR2587 as a Pfizer COVID-19 vaccine, received between 2022-09-20 and 2024-02-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
412
Reports
1%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1924%
General / Systemic (non-local)1316%
Musculoskeletal1013%
Injection-site / Local reaction810%
Cardiac / Cardiovascular79%
Thrombotic / Hematological45%
Respiratory45%
Dermatological (non-injection-site)45%
Allergic / Anaphylactic34%
Gastrointestinal34%
Psychiatric / Neuropsychiatric34%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York65
Connecticut30
California24
Minnesota23
Ohio22
Georgia21
New Jersey16
Maryland15
Maine15
Washington14
Arizona13
Texas12

Reports by month received

2022-098
2022-1043
2022-1178
2022-12109
2023-0178
2023-0243
2023-0310
2023-0412
2023-057
2023-064
2023-071
2023-082
2023-0914
2024-023

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.